Lamy Patrick (CIK 1961273) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (26,832 shares), Sell AKRO (3,059 shares), Sell AKRO (2,000 shares), Buy AKRO (193 shares), Sell AKRO (875 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | See Remarks | Sell | 26,832 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | See Remarks | Sell | 3,059 | $0 |
| 2025-07-03 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 2,000 | $105,760 |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 193 | $4,607 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 875 | $47,766 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 2,000 | $39,740 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 1,500 | $80,730 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 500 | $27,545 |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 919 | $49,626 |
| 2025-06-04 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 4,000 | $79,480 |
| 2025-06-04 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 600 | $29,640 |
| 2025-06-04 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 3,300 | $166,518 |
| 2025-06-04 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 100 | $5,104 |
| 2025-05-23 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 4,000 | $177,480 |
| 2025-05-23 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 4,000 | $200,000 |
| 2025-05-09 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 8,000 | $158,960 |
| 2025-05-09 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 4,701 | $198,899 |
| 2025-05-09 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 3,299 | $141,065 |
| 2025-03-05 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 1,000 | $19,870 |
| 2025-03-05 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 1,000 | $48,090 |
| 2025-01-29 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Sell | 5,000 | $285,150 |
| 2025-01-29 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 234 | $4,607 |
| 2025-01-29 | Akero Therapeutics, Inc. (AKRO) | Senior VP, Commercial Strategy | Buy | 4,000 | $79,480 |
Source: SEC Form 4 filings · as of 2025-12-09